Zota Health Care LImited (ZOTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zota Health Care LImited (ZOTA) has a cash flow conversion efficiency ratio of -0.220x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-499.64 Million ≈ $-5.40 Million USD) by net assets (Rs2.27 Billion ≈ $24.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zota Health Care LImited - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Zota Health Care LImited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zota Health Care LImited balance sheet liabilities for a breakdown of total debt and financial obligations.
Zota Health Care LImited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zota Health Care LImited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gravity Co Ltd
NASDAQ:GRVY
|
N/A |
|
Samse SA
PA:SAMS
|
0.077x |
|
Novavest Real Estate Ag
SW:NREN
|
0.016x |
|
Movado Group Inc
NYSE:MOV
|
0.025x |
|
Touchstone International Medical Science Co Ltd
SHG:688013
|
0.045x |
|
Styrenix Performance Materials Limited
NSE:STYRENIX
|
N/A |
|
Duni AB
ST:DUNI
|
0.044x |
|
Kangping Technology (Suzhou) Co. Ltd.
SHE:300907
|
0.021x |
Annual Cash Flow Conversion Efficiency for Zota Health Care LImited (2012–2025)
The table below shows the annual cash flow conversion efficiency of Zota Health Care LImited from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Zota Health Care LImited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.27 Billion ≈ $24.57 Million |
Rs-489.47 Million ≈ $-5.29 Million |
-0.215x | -223.99% |
| 2024-03-31 | Rs899.77 Million ≈ $9.73 Million |
Rs-59.84 Million ≈ $-647.17K |
-0.067x | -166.41% |
| 2023-03-31 | Rs803.57 Million ≈ $8.69 Million |
Rs-20.06 Million ≈ $-216.95K |
-0.025x | -116.78% |
| 2022-03-31 | Rs896.27 Million ≈ $9.69 Million |
Rs133.32 Million ≈ $1.44 Million |
0.149x | +1208.55% |
| 2021-03-31 | Rs662.97 Million ≈ $7.17 Million |
Rs-8.90 Million ≈ $-96.21K |
-0.013x | -116.66% |
| 2020-03-31 | Rs688.29 Million ≈ $7.44 Million |
Rs55.45 Million ≈ $599.62K |
0.081x | +270.99% |
| 2019-03-31 | Rs689.25 Million ≈ $7.45 Million |
Rs-32.47 Million ≈ $-351.16K |
-0.047x | +25.78% |
| 2018-03-31 | Rs697.78 Million ≈ $7.55 Million |
Rs-44.29 Million ≈ $-479.00K |
-0.063x | -143.09% |
| 2017-03-31 | Rs227.60 Million ≈ $2.46 Million |
Rs33.53 Million ≈ $362.62K |
0.147x | -25.12% |
| 2016-03-31 | Rs231.71 Million ≈ $2.51 Million |
Rs45.59 Million ≈ $492.99K |
0.197x | -16.84% |
| 2015-03-31 | Rs181.02 Million ≈ $1.96 Million |
Rs42.82 Million ≈ $463.11K |
0.237x | +23.15% |
| 2014-03-31 | Rs156.09 Million ≈ $1.69 Million |
Rs29.98 Million ≈ $324.27K |
0.192x | -3.57% |
| 2013-03-31 | Rs138.70 Million ≈ $1.50 Million |
Rs27.63 Million ≈ $298.80K |
0.199x | -0.15% |
| 2012-03-31 | Rs127.07 Million ≈ $1.37 Million |
Rs25.35 Million ≈ $274.14K |
0.199x | -- |
About Zota Health Care LImited
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more